Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
+$188M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$136M |
| 3 |
Danaher
DHR
|
+$133M |
| 4 |
Procter & Gamble
PG
|
+$112M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$101M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.29B |
| 2 |
Microsoft
MSFT
|
+$365M |
| 3 |
Alibaba
BABA
|
+$328M |
| 4 |
Ameren
AEE
|
+$220M |
| 5 |
American Electric Power
AEP
|
+$206M |
Sector Composition
| 1 | Healthcare | 20.2% |
| 2 | Technology | 12.94% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Bank of New York Mellon
BK
$73.4B
| $18.6M | 0.04% |
553,064
-4,090,619
| -88% | -$138M |
|
327
Jack Henry & Associates
JKHY
$11.8B
| $18.6M | 0.04% |
119,966
-77,012
| -39% | -$12M |
|
|
SAGE
328
DELISTED
Sage Therapeutics
SAGE
| $18.6M | 0.04% |
647,470
+584,336
| +926% | +$16.8M |
|
329
Air Products & Chemicals
APD
$64.3B
| $18.6M | 0.04% |
93,035
-15,666
| -14% | -$3.13M |
|
330
Quanta Services
PWR
$56B
| $18.5M | 0.04% |
583,337
-1,063,976
| -65% | -$33.8M |
|
331
Donaldson
DCI
$9.47B
| $18.5M | 0.04% |
478,250
+235,379
| +97% | +$9.09M |
|
332
Moderna
MRNA
$9.66B
| $18.5M | 0.04% |
+616,411
| New | +$18.5M |
|
333
Simply Good Foods
SMPL
$2.83B
| $18.5M | 0.04% |
958,517
-244,313
| -20% | -$4.71M |
|
334
Intuit
INTU
$187B
| $18.3M | 0.04% |
79,725
+43,887
| +122% | +$10.1M |
|
335
Advantage Solutions
ADV
$626M
| $18.3M | 0.04% |
+1,850,000
| New | +$18.3M |
|
336
Five Below
FIVE
$8.34B
| $18.2M | 0.04% |
258,866
-464,479
| -64% | -$32.7M |
|
337
Check Point Software Technologies
CHKP
$21.1B
| $18.2M | 0.04% |
181,116
+85,826
| +90% | +$8.63M |
|
338
American Water Works
AWK
$27.3B
| $18M | 0.04% |
150,301
-26,975
| -15% | -$3.23M |
|
339
Burlington
BURL
$18.3B
| $17.9M | 0.04% |
113,222
-147,416
| -57% | -$23.4M |
|
340
Altice USA
ATUS
$1.05B
| $17.9M | 0.04% |
803,279
+407,397
| +103% | +$9.08M |
|
341
Charles River Laboratories
CRL
$7.97B
| $17.8M | 0.04% |
140,772
-330,998
| -70% | -$41.8M |
|
342
Carlisle Companies
CSL
$16.8B
| $17.8M | 0.04% |
141,814
-138,208
| -49% | -$17.3M |
|
343
Fate Therapeutics
FATE
$111M
| $17.7M | 0.04% |
799,035
-776,073
| -49% | -$17.2M |
|
|
SUM
344
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $17.7M | 0.04% |
1,203,220
-1,793,648
| -60% | -$26.5M |
|
345
ONE Gas
OGS
$4.47B
| $17.7M | 0.04% |
+211,631
| New | +$17.7M |
|
346
Ross Stores
ROST
$49.6B
| $17.7M | 0.04% |
203,044
-3,160
| -2% | -$275K |
|
347
Cytokinetics
CYTK
$6.23B
| $17.6M | 0.04% |
1,490,927
-1,080,630
| -42% | -$12.7M |
|
348
TechnipFMC
FTI
$16.1B
| $17.5M | 0.04% |
3,496,939
+400,371
| +13% | +$2.01M |
|
349
Fair Isaac
FICO
$36.9B
| $17.5M | 0.04% |
56,980
+28,563
| +101% | +$8.79M |
|
|
NTCO
350
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $17.5M | 0.04% |
+1,779,618
| New | +$17.5M |
|